Literature DB >> 10797392

Chronic motor axonal neuropathy associated with antibodies monospecific for N-acetylgalactosaminyl GD1a.

R Kaji1, S Kusunoki, K Mizutani, N Oka, Y Kojima, N Kohara, J Kimura.   

Abstract

We report on three patients with chronic motor neuropathy who had elevated titers of immunoglobulin (Ig)G antibodies against N-acetylgalactosaminyl GD1a (GalNAc-GD1a) and normal titers of antibodies against other gangliosides. Presenting with progressive muscular atrophy, fasciculations, and no sensory deficits, the patients had been diagnosed to have motor neuron disease. Electrodiagnostic features were predominantly axonal. Two patients clinically improved after intravenous Ig infusion and cyclophosphamide therapy. Increased titers of IgM antibodies to GalNAc-GD1a were also found in two of 15 patients with multifocal motor neuropathy with conduction block but were associated with concomitant rise of anti-GM1 antibodies. These three cases represent a chronic motor axonal neuropathy in which antibody testing for a minor ganglioside was helpful for instituting therapy. Copyright 2000 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10797392     DOI: 10.1002/(sici)1097-4598(200005)23:5<702::aid-mus6>3.0.co;2-a

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  5 in total

1.  Subacute motor axonal neuropathy associated with the IgG anti-GalNAc-GD1a antibody.

Authors:  Hirofumi Goto; Takayasu Fukudome; Susumu Kusunoki; Hidenori Matsuo
Journal:  BMJ Case Rep       Date:  2011-03-29

2.  Diagnosis and treatment of multifocal motor neuropathy.

Authors:  Ryuji Kaji
Journal:  Curr Treat Options Neurol       Date:  2008-03       Impact factor: 3.598

3.  Enhanced expression of unique gangliosides with GM2-determinant in human uterine cervical carcinoma-derived cell lines.

Authors:  Kyoko Tanaka; Masaki Miyazawa; Mikio Mikami; Daisuke Aoki; Kazushige Kiguchi; Masao Iwamori
Journal:  Glycoconj J       Date:  2016-06-06       Impact factor: 2.916

4.  Ambiguous value of anti-ganglioside IgM autoantibodies in Guillain-Barré syndrome and its variants.

Authors:  Michiaki Koga; Masaki Takahashi; Keiko Yokoyama; Takashi Kanda
Journal:  J Neurol       Date:  2015-06-09       Impact factor: 4.849

5.  Sporadic Amyotrophic Lateral Sclerosis Due to a FUS P525L Mutation with Asymmetric Muscle Weakness and Anti-ganglioside Antibodies.

Authors:  Masanobu Tanemoto; Shin Hisahara; Kazuna Ikeda; Kazuki Yokokawa; Tatsuo Manabe; Reiko Tsuda; Daisuke Yamamoto; Takashi Matsushita; Akihiro Matsumura; Syuuichirou Suzuki; Shun Shimohama
Journal:  Intern Med       Date:  2021-02-01       Impact factor: 1.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.